A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Clinical trial NCT05989724 · UNKNOWN
Trial details
- NCT number
- NCT05989724
- Sponsor
- Qurgen Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2025-09-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.